-
MEDICATION ADHERENCE, TREATMENT SATISFACTION IN PATIENTS WITH MOOD DISORDERS AT A SAUDI TERTIARY CARE HOSPITAL: A CROSS-SECTIONAL STUDY
Aug 11, 2026, 17:15 PM -
THE IMPACT OF SF-6D HEALTH UTILITY ON PRODUCTIVITY LOSS: A POPULATION-BASED OBSERVATIONAL STUDY
Aug 11, 2026, 17:15 PM -
FIXED-DOSE SUBCUTANEOUS RITUXIMAB VERSUS BSA-ROUNDED IV BIOSIMILAR: A COST-CONSEQUENCE ANALYSIS OF AN AS-PRACTICED MIXED FORMULARY AT SSMC A TERTIARY ONCOLOGY CENTRE IN THE MIDDLE EAST
Aug 11, 2026, 17:15 PM -
ADAPTIVE HTA FOR GENE THERAPIES AND ORPHAN DRUGS IN MENA REGION: A REGIONAL EXPERT CONSENSUS ON SUSTAINABLE AND EQUITABLE ACCESS
Aug 11, 2026, 17:15 PM -
METHODOLOGICAL AND STATISTICAL LEARNINGS FROM INITIAL JOINT CLINICAL ASSESSMENT REPORTS UNDER THE EU HTA REGULATION: CROSS-COMPANY PERSPECTIVES
Aug 11, 2026, 17:15 PM -
COST IMPLICATIONS OF DECLINING MMR COVERAGE IN ENGLAND: A TWO-COHORT ANALYSIS OF NHS BURDEN AND CATCH-UP VACCINATION VALUE
Aug 11, 2026, 17:15 PM -
MULTIDIMENSIONAL BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND FAMILY IMPACT IN ALGERIA: A PHYSICIAN REPORTED ASSESSMENT
Aug 11, 2026, 17:15 PM -
ANTICIPATING THE VALUE- AND PRICE-DETERMINATION CHALLENGE OF GLP-1 RA INDICATION EXPANSION ACROSS HETEROGENEOUS THERAPEUTIC AREAS: LESSONS FROM PD-1/PD-L1 AND TNF-α INHIBITORS INDICATION EXPANSION
Aug 11, 2026, 17:15 PM -
A SYSTEMATIC LITERATURE REVIEW OF ECONOMIC EVALUATIONS AND HEALTH UTILITY VALUES IN MODERATE-TO-SEVERE HIDRADENITIS SUPPURATIVA
Aug 11, 2026, 17:15 PM -
KWIT: A DIGITAL APPROACH TO SUPPORT COPD SCREENING AND MONITORING - RESULTS FROM AN INNOVATIVE APPROACH IN FRANCE
Aug 11, 2026, 17:15 PM -
REVERSING FINLAND'S LONG-TERM DECLINE IN INDUSTRY-SPONSORED CLINICAL TRIALS COULD ADD OVER €1 BILLION IN SOCIETAL VALUE BY 2030
Aug 11, 2026, 17:15 PM -
VARIATION IN CONCEPTUAL AND OPERATIONAL DEFINITIONS OF DEPRESSION IN REAL-WORLD RESEARCH
Aug 11, 2026, 17:15 PM -
HIGH BURDEN OF DEPRESSION AND ANXIETY IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM GERMAN CLAIMS AND CLINICAL DATA
Aug 11, 2026, 17:15 PM -
COMPARATIVE EFFECTIVENESS OF GABAPENTIN ALONE AND MEMANTINE WITH GABAPENTIN IN DIABETIC NEUROPATHY PATIENTS: EVIDENCE TO SUPPORT CLINICAL DECISION-MAKING
Aug 11, 2026, 17:15 PM -
DECODING CLINICAL HEURISTICS IN EARLY ALZHEIMER'S DISEASE: NEUROLOGISTS' PREFERENCES AND TRADE-OFFS IN AMYLOID-TARGETING THERAPY INITIATION
Aug 11, 2026, 17:15 PM -
ESMO-MCBS: DO CURRENT CRITERIA UNDERVALUE CLINICAL BENEFIT IN POOR-PROGNOSIS POPULATIONS
Aug 11, 2026, 17:15 PM -
BURDEN OF PREVENTABLE MEDICATION ERRORS IN SPAIN: CLINICAL AND ECONOMIC IMPACT, AND THE POTENTIAL OF HEALTH TECHNOLOGIES
Aug 11, 2026, 17:15 PM -
HAS FRANCE'S EARLY ACCESS SCHEME BECOME MORE SELECTIVE? EVIDENCE FROM TEMPORAL TRENDS IN EARLY ACCESS AND SUBSEQUENT ASMR RATINGS
Aug 11, 2026, 17:15 PM -
MENTAL HEALTH HEOR EVIDENCE GENERATION AND GROWTH OF REAL-WORLD EVIDENCE AMID INCREASING DISEASE BURDEN: AN AI-ASSISTED LONGITUDINAL ANALYSIS, 2014-2023
Aug 11, 2026, 17:15 PM -
RETURN ON INVESTMENT OF ONE-TIME LIPOPROTEIN(A) TESTING FOR CARDIOVASCULAR RISK PREVENTION IN BULGARIA
Aug 11, 2026, 17:15 PM
